Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Middle East Journal of Anesthesiology 2014-Feb

GlideScope videolaryngoscope versus flexible fiberoptic bronchoscope for awake intubation of morbidly obese patient with predicted difficult intubation.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Länken sparas på Urklipp
Ashraf Abualhasan Abdellatif
Monaz Abdulrahman Ali

Nyckelord

Abstrakt

BACKGROUND

Awake fiberoptic intubation is the gold standard for management of predicted difficult intubation. The purpose of this study was to test whether Glide Scope video laryngoscopy (GVL) will provide significant advantages over fiberoptic bronchoscopy (FOB) for awake intubation in morbidly obese patients with predicted difficult intubation. We therefore tested the hypothesis that intubation using GVL is faster than intubation with FOB.

METHODS

64 morbidly obese patients with predicted difficult intubation undergoing laparoscopic bariatric surgery were enrolled in this study. Patients were randomly assigned to receive awake oral intubation by either GVL or FOB. After airway topical anesthesia and sedation using target controlled remifentanil infusion to a Ramsay sedation scale of 3, wee compared the two devices for time to intubate, successful intubation on first attempt, glottic view using Cormack and Lehane score system, response of the patient to scope, patients satisfaction and incidence of postoperative sore throat and hoarseness.

RESULTS

Intubation time was 84 +/- 37.9 seconds and 73.6 +/- 31.1 seconds for FOB and GVL respectively. 75% of patients were successfully intubated on the first attempt with FOB compared to 80.6% with GVL. Grade I/II glottic view was reported with GVL in 96.7% of patients compared to 100% with FOB. The highest target concentration of remifentanil to maintain patients sedated during intubation was 2.4 +/- 0.6 ng/ml and 2.2 +/- 0.8 ng/ml in FOB and GVL respectively. No significant differences regarding maximum patient response to intubation, adverse effects or patient satisfaction were recorded between groups.

CONCLUSIONS

GVL can be used as a useful alternative to FOB in morbidly obese patients with predicted difficult intubation.

Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge